Syndrome de Sjögren: enfin une nouvelle approche de traitement [Sjögren's syndrome: a new approach to treatment].


Autoria(s): Rossier V.; Bart P.A.; Spertini F.
Data(s)

2012

Resumo

Södgren's syndrome treatment has essentially been based on symptomatic approach and has been of limited efficacy. Novel biological therapies targeting B cells, a key player in the pathophysiology of the syndrome, have recently been tested in controlled clinical trials and raise the hope of improving glandular and extraglandular manifestations of Söigren's syndrome.

Identificador

http://serval.unil.ch/?id=serval:BIB_1ED13D02C38D

isbn:1660-9379 (Print)

pmid:22594008

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 8, no. 337, pp. 843-847

Palavras-Chave #Antibodies, Monoclonal, Murine-Derived/therapeutic use; Antirheumatic Agents/therapeutic use; Clinical Trials as Topic; Humans; Muscarinic Agonists/therapeutic use; Sjogren's Syndrome/complications; Sjogren's Syndrome/drug therapy
Tipo

info:eu-repo/semantics/article

article